Edap Tms (NASDAQ:EDAP) Coverage Initiated by Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Edap Tms (NASDAQ:EDAP - Get Free Report) in a research report issued on Sunday. The firm set a "hold" rating on the medical equipment provider's stock.

Other equities analysts also recently issued research reports about the stock. Piper Sandler cut their price target on shares of Edap Tms from $5.00 to $4.50 and set an "overweight" rating on the stock in a research note on Friday, March 28th. HC Wainwright reaffirmed a "buy" rating and issued a $19.00 target price on shares of Edap Tms in a research report on Friday, March 28th. Finally, Jefferies Financial Group reissued a "hold" rating and set a $2.00 price target (down previously from $8.00) on shares of Edap Tms in a research report on Friday, April 4th.

Edap Tms Price Performance

EDAP stock traded down $0.02 on Friday, reaching $1.36. The company had a trading volume of 88,119 shares, compared to its average volume of 93,290. Edap Tms has a 1 year low of $1.26 and a 1 year high of $7.73. The company has a market cap of $50.46 million, a P/E ratio of -2.09 and a beta of 0.12. The company's fifty day moving average is $2.24 and its 200 day moving average is $2.37. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 2.18.

Remove Ads

Edap Tms (NASDAQ:EDAP - Get Free Report) last announced its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The business had revenue of $22.69 million for the quarter, compared to the consensus estimate of $20.83 million. On average, research analysts forecast that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Investors Weigh In On Edap Tms

Several large investors have recently made changes to their positions in the business. BNP Paribas Financial Markets grew its stake in shares of Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider's stock valued at $59,000 after buying an additional 4,400 shares in the last quarter. Illumine Investment Management LLC bought a new position in Edap Tms during the 4th quarter valued at $50,000. Rock Springs Capital Management LP grew its holdings in Edap Tms by 1.5% during the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider's stock worth $3,518,000 after acquiring an additional 23,800 shares in the last quarter. Schonfeld Strategic Advisors LLC increased its position in shares of Edap Tms by 48.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider's stock worth $355,000 after purchasing an additional 52,500 shares during the last quarter. Finally, Jane Street Group LLC raised its stake in shares of Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock valued at $69,000 after purchasing an additional 73,361 shares in the last quarter. Institutional investors and hedge funds own 62.74% of the company's stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.